In a multicentre cohort of patients with unifocal HCC, patients with very early stage disease had a survival advantage over patients diagnosed at an early stage. Factors associated with mortality included worse liver function, larger tumour size and higher AFP levels.
Thomas Hunold +4 more
wiley +1 more source
Yttrium-90 radioembolization as an in vivo immune modulator: clinical evidence and pharmacologic implications. [PDF]
Tang S, Cai J, Wu P, Wang G.
europepmc +1 more source
Yttrium-90-Induced Gastropathy: A Potential Equivocal Finding
Rui Castro +4 more
doaj +1 more source
Yttrium-90 radioembolization for treatment of anaplastic meningioma liver metastases. [PDF]
Fassia MK +9 more
europepmc +1 more source
Yttrium-90 radioembolization for primary and metastatic liver tumors exhibiting arterial-phase hypovascularity. [PDF]
Malavia M +8 more
europepmc +1 more source
Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review. [PDF]
Yang T, Zhang L, Xu W, Zheng C, Liang B.
europepmc +1 more source
Prolonged Radiation-Induced Gastritis Following Yttrium-90 Radioembolization: A Case of Persistent Dyspepsia and Endoscopic Surveillance. [PDF]
Latif MH +4 more
europepmc +1 more source
Liver hypertrophy post-Yttrium-90 versus portal vein embolization: A systematic review and meta-analysis. [PDF]
Virani SS +6 more
europepmc +1 more source
Feasibility of Radioembolization With Yttrium-90 Resin Microspheres Without Lung Shunt Fraction Measurement for Intrahepatic Cholangiocarcinoma. [PDF]
Lee M, Kim DH, Suh M, Paeng JC, Kim HC.
europepmc +1 more source
Epithelial-Mesenchymal Transition and Stress Adaptations Underlie Yttrium-90 Resistance in Liver Cancer Cell Lines. [PDF]
Zheleznyak A +15 more
europepmc +1 more source

